The President and CEO of ADBC member Novozymes, Peder Holk Nielsen, joined U.S. President Barack Obama and other international business leaders at the White House in May for a roundtable discussion on investing in the United States.
President Obama and the business leaders discussed the opportunities for locating, growing and hiring in the U.S. and key factors that would encourage further investment.
The meeting was part of the Administration’s efforts to highlight the U.S. Department of Commerce’s SelectUSA program, which promotes the U.S. as a premiere location for business and investment.
ADBC board member and director of government and public affairs at Novozymes, Chris Bender, reported that “Novozymes was flattered by the invitation, which we see as a product of all the work and investments we’ve made in the U.S.” Talking about the future Chris Bender said that “we see the US as a market with lots of potential and strong, stable policy is critical to growing it. We’re proud to have opened a $200 million plant in Blair, Nebraska – we’ve got more than 100 Nebraskans and Iowans making enzymes, working in labs and more there. Policies like the Renewable Fuels Standard were central to the decision to invest in the US.”
In April, Novozymes announced the establishment of a new U.S.-based research and development center dedicated to its BioAgriculture business. The center will be located near the Research Triangle Park in Cary, North Carolina where the company will invest $36 million over the next three years and create 100 new research and development jobs.
Photo credit: ASSOCIATED PRESS